SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-171388
Filing Date
2019-06-12
Accepted
2019-06-12 17:13:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 424(B)(5) d765842d424b5.htm 424B5 368880
2 GRAPHIC g765842g40y10.jpg GRAPHIC 61533
  Complete submission text file 0001193125-19-171388.txt   454813
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-216735 | Film No.: 19894263
SIC: 2834 Pharmaceutical Preparations